Antibiotics cut COPD exacerbations

Antibiotic treatment of COPD with azithromycin reduces exacerbations by a quarter, but may affect some patients' hearing, a US study suggests.

COPD patients were treated with azithromycin for a year (Photograph: SPL)
COPD patients were treated with azithromycin for a year (Photograph: SPL)

However, the impact of such a treatment strategy on antibiotic resistance is not yet known, researchers warned.

Dr Richard Albert and colleagues from the US COPD Clinical Research Network examined the effect of treatment on 1,142 patients.

Patients enrolled in the trial were at increased risk of COPD exacerbations but had no hearing impairment.

Also, because of the effect of azithromycin on QT interval, patients at apparent risk of prolongation of corrected QT interval were excluded.

Patients were randomised to receive either azithromycin 250mg daily or a placebo for one year.

Those given azithromycin experienced exacerbation after an average of 266 days, compared with 174 days for patients given placebo.

Frequency of exacerbations was 1.48 per patient-year in the azithromycin group, compared with 1.83 in the placebo group. Patients given azithromycin were 27% less likely to experience an exacerbation within the year of treatment.

However, hearing decrements were experienced by 25% of the azithromycin group, compared with 20 per cent of the placebo group.

The researchers said: 'Given the deleterious effects of acute exacerbations of COPD with respect to the risk of death, quality of life, loss of lung function, and cost of care, adding azithromycin to the treatment regimen of patients who have had an acute exacerbation of COPD within the previous year or who require supplemental oxygen is a valuable option.'

The researchers said patients should be screened for risk of prolongation of corrected QT interval and have their hearing monitored.

They added: 'It should be recognised that the long-term effects of this treatment on microbial resistance in the community are not known.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Advance decisions to refuse treatment - what GPs need to know

Advance decisions to refuse treatment - what GPs need to know

A recent case has underlined the need for GPs to communicate a patient’s known wishes...

Law changed to allow physios and paramedics to administer vaccines during pandemic

Law changed to allow physios and paramedics to administer vaccines during pandemic

A wider range of healthcare workers will be allowed to administer flu and potential...

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages drive up GP workload as prescribing costs surge £158m

Medicines shortages in England are continuing to drive up GP workload during the...

Arrhythmias - red flag symptoms

Arrhythmias - red flag symptoms

Dr Pipin Singh provides an overview of red flag symptoms in patients with arrhythmias.

How have GP practices fared under CQC inspections?

How have GP practices fared under CQC inspections?

The latest annual report from the CQC sets out ratings for all of the sectors it...

CQC flags concern over GP access despite 2m face-to-face appointments last week

CQC flags concern over GP access despite 2m face-to-face appointments last week

The CQC plans to 'follow up' concerns about access to face-to-face GP services, warning...